We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 10,000 results
  1. Cancer Care Delivery Among Breast Cancer Patients: Is it the Same for All?

    Among Hispanic women, breast cancer is the most common cancer accounting for close to 30% of the total cancer cases. It is estimated that in 2018...
    Catalina Malinowski, Mariana Chavez Mac Gregor in Advancing the Science of Cancer in Latinos
    Chapter Open access 2023
  2. Impact of media compositions and culture systems on the immunophenotypes of patient-derived breast cancer cells

    Background

    Heterogeneous tumor cells are thought to be a significant factor in the failure of endocrine therapy in estrogen receptor-positive (ER+)...

    Seungyeon Ryu, So-Hyun Yoon, ... Wonshik Han in BMC Cancer
    Article Open access 06 September 2023
  3. Breast density knowledge and willingness to delay treatment for pre-operative breast cancer imaging among women with a personal history of breast cancer

    Background

    Following a breast cancer diagnosis, it is uncertain whether women’s breast density knowledge influences their willingness to undergo...

    Rebecca E. Smith, Brian L. Sprague, ... Anna N.A. Tosteson in Breast Cancer Research
    Article Open access 29 April 2024
  4. CDK Dysregulation in Breast Cancer: A Bioinformatics Analysis

    Breast cancer is one of the most common types of malignancy diagnosed among females worldwide. Due to its heterogenous nature, the type of treatment...
    Manzoor Ahmad Mir, Shazia Sofi, Pir M. Ishfaq in Therapeutic potential of Cell Cycle Kinases in Breast Cancer
    Chapter 2023
  5. Patient-Derived Breast Cancer Tissue Cultures for Anti-Endocrine Drug Assays

    BreastCancerBreast cancer is a complex and heterogeneous pathology, characterized by a variety of histological and molecular phenotypes. The majority...
    Giacomo Domenici, Gonçalo Trindade, ... Catarina Brito in Cancer Drug Resistance
    Protocol 2022
  6. Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin

    Background

    The intratumor heterogeneity (ITH) of cancer cells plays an important role in breast cancer resistance and recurrence. To develop better...

    Sumito Saeki, Kohei Kumegawa, ... Reo Maruyama in Breast Cancer Research
    Article Open access 21 February 2023
  7. Breast Cancer Xenograft Murine Models

    Mice are used as model organisms to understand the pathological basis of a variety of human diseases, including breast cancer. Both immunocompetent...
    Wasundara Fernando, Krysta M. Coyle, Paola Marcato in Cancer Cell Biology
    Protocol 2022
  8. Unveiling Strategies to Conquer Virus-Induced Breast Cancer Drug Resistance

    One of the primary causes of cancer-related deaths among women worldwide is breast cancer (BC). Conventional medical approaches to treating breast...
    Boitumelo Phakathi, Benny Mosoane, ... Zodwa Dlamini in Overcoming Breast Cancer Therapy Resistance
    Chapter 2024
  9. Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30

    Adjuvant chemotherapy improves breast cancer survival but is associated with bothersome short- and long-term toxicity. Factors associated with...

    N. Lynn Henry, Sung** Kim, ... Patricia A. Ganz in npj Breast Cancer
    Article Open access 19 November 2022
  10. Impact of Obesity and Related Factors in Breast Cancer Survivorship Among Hispanic Women

    Breast cancer is the leading cause of death among Hispanic women. The number of Hispanic breast cancer survivors is increasing because the US...
    Elisa V. Bandera, Chi-Chen Hong, Bo Qin in Advancing the Science of Cancer in Latinos
    Chapter Open access 2023
  11. Guideline-concordant breast cancer care by patient race and ethnicity accounting for individual-, facility- and area-level characteristics: a SEER-Medicare study

    Purpose

    To examine racial–ethnic variation in adherence to established quality metrics (NCCN guidelines and ASCO quality metrics) for breast cancer,...

    Emma L. Herbach, Michaela Curran, ... Mary Charlton in Cancer Causes & Control
    Article 28 March 2024
  12. Tumor Heterogeneity in Breast Cancer Progression

    Cancer is an aberrant growth of cells with dynamic molecular changes as the disease progresses. As a result of these dynamic changes and an increase...
    Yasaswi Gayatri Mishra, Sruchytha Kalali, ... Bramanandam Manavathi in Handbook of Oncobiology: From Basic to Clinical Sciences
    Reference work entry 2024
  13. Nucleosome reorganisation in breast cancer tissues

    Background

    Nucleosome repositioning in cancer is believed to cause many changes in genome organisation and gene expression. Understanding these...

    Divya R. Jacob, Wilfried M. Guiblet, ... Vladimir B. Teif in Clinical Epigenetics
    Article Open access 01 April 2024
  14. CDk Inhibitor for Treatment of Breast Cancer

    A complicated interaction of Cyclins and cyclin-dependent kinases (CDKs) drives the mammalian cell cycle and one of the main causes or hallmarks of...
    Manzoor Ahmad Mir, Aabida Gul, ... M. Sultan Khan in Therapeutic potential of Cell Cycle Kinases in Breast Cancer
    Chapter 2023
  15. Predicting early breast cancer recurrence from histopathological images in the Carolina Breast Cancer Study

    Approaches for rapidly identifying patients at high risk of early breast cancer recurrence are needed. Image-based methods for prescreening...

    Yifeng Shi, Linnea T. Olsson, ... Melissa A. Troester in npj Breast Cancer
    Article Open access 11 November 2023
  16. Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer

    Patient-derived xenograft (PDX) models of breast cancer are an effective discovery platform and tool for preclinical pharmacologic testing and...

    Gloria V. Echeverria, Shirong Cai, ... Helen Piwnica-Worms in npj Breast Cancer
    Article Open access 10 January 2023
  17. Impact of timing and format of patient decision aids for breast cancer patients on their involvement in and preparedness for decision making - the IMPACTT randomised controlled trial protocol

    Background

    After curative surgery for early-stage breast cancer, patients face a decision on whether to undergo surgery alone or to receive one or...

    Bettina Mølri Knudsen, Stine Rauff Søndergaard, ... Karina Dahl Steffensen in BMC Cancer
    Article Open access 12 March 2024
  18. Patient Navigation for Cancer Screening and Treatment

    Differences in key social determinants of health between racial and ethnic, socioeconomic, or geographic groups result in differential barriers to...
    Evan M. Graboyes, Elizabeth A. Calhoun in Cancer Health Disparities
    Chapter 2023
  19. Current status and challenges of breast cancer prevention~DNA methylation would lead to groundbreaking progress in breast cancer prevention~

    The number of breast cancer patients is increasing worldwide. Furthermore, breast cancer often develops in young people, even those only in their...

    Takahiro Tsukioki, Seema A. Khan, Tadahiko Shien in Genes and Environment
    Article Open access 12 December 2023
  20. Radiotherapy refusal in breast cancer with breast-conserving surgery

    Background

    Although radiotherapy after breast-conserving surgery has been the standard treatment for breast cancer, some people still refuse to...

    Jiameng Liu, Zhanlin Zhu, ... Jujiang Guo in Radiation Oncology
    Article Open access 05 August 2023
Did you find what you were looking for? Share feedback.